Anavex Life Sciences Statistics
NASDAQ: AVXLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.46-0.085 (-5.52%)
Market open · Delayed 15 min · as of Oct 9, 12:46 PM ET
Anavex Life Sciences by the numbers
Anavex Life Sciences has a market capitalization of $134.9 million based on 92.70M shares outstanding. With trailing EPS of $-0.14, Anavex Life Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 46.7% below its 50-day average and 55.9% below its 200-day average.
Average daily trading volume is 979.69K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AVXL valuation vs. peer median
| Metric | AVXL | Peer median | Difference |
|---|---|---|---|
| Market cap | $134.87M | $146.96M | -8% |
| Avg. volume | 979.69K | 693.97K | +41% |
Peer median across 8 companies: ARMP, MOLN, OTLK, VYGR, ABOS, CRDL, TNYA, TARA.
Valuation
- Market cap
- $134.87M
- EPS (TTM)
- $-0.14
- Shares outstanding
- 92.70M
Price and trading
- Previous close
- 1.54
- Open
- 1.54
- Day range
- 1.44 – 1.54
- 52-week range
- 1.44 – 9.53
- 52-week change
- -84.37%
- Beta
- —
- Volume
- 587.28K
- Average volume
- 979.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 24, 2026
Additional statistics
- Market Cap
- 134.87M
- Forward Pe
- -2.65
- Eps
- -0.14
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.53
- Week52 Low
- 1.44
- Avg Volume
- 979.69K
- Shares Outstanding
- 92.70M
- Ma50
- 2.73
- Ma200
- 3.30
- Earnings Date
- Nov 24, 2026
- Pct From52w High
- -84.72%
- Pct From52w Low
- 1.04%